Trial results for an educational intervention in newly diagnosed Type 1 Diabetes were posted on 2025-12-17. The terminated study found that tablet-based education improved patient knowledge scores from a mean of 83% to 86% and reduced the mean number of hypoglycemic episodes from 4.2 to 1.
Background
Type 1 Diabetes Mellitus is a chronic autoimmune condition requiring lifelong management, particularly for newly diagnosed patients. Effective education is critical for patients and their families to understand glucose monitoring, insulin administration, and complication prevention, including hypoglycemia. Standard education often relies on paper-based materials and nursing instruction. This trial explored whether supplementing standard education with bedside tablet modules could enhance learning and improve clinical outcomes.
Trial design
This prospective, randomized trial, designated as "NA" phase, investigated the effectiveness of educational modules delivered via bedside tablet in patients newly diagnosed with Type 1 Diabetes Mellitus. The study enrolled 28 participants before its termination. The intervention compared standard Children's Hospital-Molly Center diabetes education (consisting of paper-based reading material and nursing education) against standard education supplemented with educational modules accessed through a bedside tablet.
Key results
The trial reported on several key measurements comparing the two educational approaches:
- Effectiveness of Tablet Education in Newly Diagnosed Type 1 Diabetes (measured as percentage of questions answered correct):
- The "Standard Diabetes Education" group achieved a mean of 83%.
- The "Standard Diabetes Education and Tablet" group achieved a mean of 86%.
- Improved Subject Compliance With Glucose Monitoring A1 Levels (measured as percentage change in HbA1C):
- The "Standard Diabetes Education" group showed a mean of 8%.
- The "Standard Diabetes Education and Tablet" group showed a mean of 8.06%.
- Improved Subject Compliance With Glucose Monitoring - Hypoglycemic Episodes (measured as number of Hypoglycemic Episodes):
- The "Standard Diabetes Education" group had a mean of 4.2 episodes.
- The "Standard Diabetes Education and Tablet" group had a mean of 1 episode.
What this means
The results from this terminated trial suggest that supplementing standard Type 1 Diabetes education with bedside tablet modules may offer a modest improvement in patient knowledge, as indicated by a 3% increase in mean correct answers. More notably, the data indicates a substantial reduction in the mean number of hypoglycemic episodes, from 4.2 to 1, in the group receiving tablet education. However, the impact on HbA1C levels was minimal, with both groups showing similar mean percentage changes. Given the trial's termination and small enrollment of 28 participants, these findings should be interpreted cautiously, but they point to a potential benefit of digital educational tools in improving immediate patient understanding and reducing acute complications like hypoglycemia in newly diagnosed individuals.
Source
The information for these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT03534193, titled "Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes", were posted on 2025-12-17 on clinicaltrials.gov.